BIO-key Int.

BIO-key International, Inc. engages in the provision of identity and access management (IAM) platform.The firm's products include multi-factor authentication, self-service password reset, single sign-on, fingerprint scanners, and civil and large-scale identification.It offers its services to the education, financial, government, healthcare, manufacturing, and retail industries.The company was founded on January 7, 1993 and is headquartered in Wall, NJ.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

BIO-key Boosts Revenue, Launches New IAM Product

BIO-key International has shown notable improvements in its financial and operational performance in Q1 2024, marked by increased revenues, higher profit margins, and reduced losses. The company's strategic initiatives and new product launches are set to address the expanding market needs in identity management, despite facing challenges related to inventory management and market competition.

BIO-key reports Q2 revenue decline, focuses on growth strategies

BIO-key's Q2 2024 performance was impacted by revenue decline from software contract delays.
Despite challenges, the company showcased strengths in new product offerings and global market expansion.
Opportunities lie in strategic partnerships and CEO optimism for future growth and profitability.

BIO-key Int. (BKYI) reports robust Q3 performance and growth opportunities

BIO-key International demonstrated strong revenue growth and margin improvements in Q3 '24, driven by high-margin license revenue and cost controls.
The company's focus on enhancing security, reducing fraud, and expanding market reach through strategic partnerships positions them for future success.
While challenges in achieving profitability persist, BIO-key's strategic initiatives and focus on recurring revenues offer promising growth prospects.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

BIO-key International, Inc. engages in the provision of an identity and access management platform. The firm's products include PortalGuard, Admin Panel, Hardware, Identity-Bound Biometrics, and MobileAuth. It offers its services to the education, finance, government, healthcare, manufacturing, and retail industries. The company was founded on January 7, 1993 and is headquartered in Holmdel, NJ.

BIO-key International, Inc. (BKYI) CEO Mike DePasquale on Q4 2018 Results - Earnings Call Transcript

News for BIO-key Int. Stock (BKYI)